Interpretation of Incidence Rates Data
Incidence Rate Report by State
Non-Hodgkin Lymphoma (Late Stage^), 2016-2020
All Races (includes Hispanic), Female, All Ages
Sorted by Count
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 9.7 with a 95% confidence interval from 9.6 to 9.7 and 19,778 average annual cases over 2016-2020.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : 62.8
District of Columbia6
- Rate : The incidence rate is 7.5 with a 95% confidence interval from 6.3 to 8.9 and 28 average annual cases over 2016-2020.
- CI*Rank⋔ : 47 (30, 49)
- Percent of Cases with Late Stage : 65.0
Wyoming6
- Rate : The incidence rate is 8.0 with a 95% confidence interval from 6.7 to 9.5 and 29 average annual cases over 2016-2020.
- CI*Rank⋔ : 42 (19, 49)
- Percent of Cases with Late Stage : 62.4
Alaska6
- Rate : The incidence rate is 9.3 with a 95% confidence interval from 7.9 to 10.9 and 33 average annual cases over 2016-2020.
- CI*Rank⋔ : 34 (2, 48)
- Percent of Cases with Late Stage : 63.7
Vermont6
- Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.2 to 10.8 and 45 average annual cases over 2016-2020.
- CI*Rank⋔ : 32 (3, 46)
- Percent of Cases with Late Stage : 64.2
North Dakota6
- Rate : The incidence rate is 9.9 with a 95% confidence interval from 8.6 to 11.3 and 45 average annual cases over 2016-2020.
- CI*Rank⋔ : 23 (1, 44)
- Percent of Cases with Late Stage : 64.3
South Dakota6
- Rate : The incidence rate is 11.4 with a 95% confidence interval from 10.1 to 12.8 and 63 average annual cases over 2016-2020.
- CI*Rank⋔ : 3 (1, 32)
- Percent of Cases with Late Stage : 68.3
Delaware6
- Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.4 to 10.6 and 66 average annual cases over 2016-2020.
- CI*Rank⋔ : 31 (6, 44)
- Percent of Cases with Late Stage : 66.5
Montana6
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 8.6 to 10.7 and 71 average annual cases over 2016-2020.
- CI*Rank⋔ : 28 (4, 42)
- Percent of Cases with Late Stage : 67.5
Rhode Island6
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 8.8 to 10.9 and 72 average annual cases over 2016-2020.
- CI*Rank⋔ : 25 (3, 41)
- Percent of Cases with Late Stage : 62.3
Hawaii3
- Rate : The incidence rate is 7.6 with a 95% confidence interval from 6.8 to 8.5 and 75 average annual cases over 2016-2020.
- CI*Rank⋔ : 46 (37, 49)
- Percent of Cases with Late Stage : 61.4
New Mexico3
- Rate : The incidence rate is 6.3 with a 95% confidence interval from 5.7 to 6.9 and 88 average annual cases over 2016-2020.
- CI*Rank⋔ : 49 (47, 49)
- Percent of Cases with Late Stage : 51.6
New Hampshire6
- Rate : The incidence rate is 10.5 with a 95% confidence interval from 9.6 to 11.5 and 100 average annual cases over 2016-2020.
- CI*Rank⋔ : 12 (1, 36)
- Percent of Cases with Late Stage : 60.4
Puerto Rico6
- Rate : The incidence rate is 5.0 with a 95% confidence interval from 4.5 to 5.4 and 108 average annual cases over 2016-2020.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : 40.7
Idaho3
- Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.3 to 11.0 and 108 average annual cases over 2016-2020.
- CI*Rank⋔ : 18 (3, 38)
- Percent of Cases with Late Stage : 66.8
Maine6
- Rate : The incidence rate is 10.6 with a 95% confidence interval from 9.7 to 11.6 and 112 average annual cases over 2016-2020.
- CI*Rank⋔ : 11 (1, 34)
- Percent of Cases with Late Stage : 69.3
Nebraska6
- Rate : The incidence rate is 10.3 with a 95% confidence interval from 9.5 to 11.2 and 123 average annual cases over 2016-2020.
- CI*Rank⋔ : 15 (2, 36)
- Percent of Cases with Late Stage : 62.7
Utah3
- Rate : The incidence rate is 9.7 with a 95% confidence interval from 9.0 to 10.4 and 143 average annual cases over 2016-2020.
- CI*Rank⋔ : 27 (7, 39)
- Percent of Cases with Late Stage : 66.9
Mississippi6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.2 to 8.3 and 148 average annual cases over 2016-2020.
- CI*Rank⋔ : 44 (39, 48)
- Percent of Cases with Late Stage : 58.7
West Virginia6
- Rate : The incidence rate is 11.2 with a 95% confidence interval from 10.4 to 12.1 and 149 average annual cases over 2016-2020.
- CI*Rank⋔ : 5 (1, 22)
- Percent of Cases with Late Stage : 68.8
Arkansas6
- Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.3 to 9.5 and 180 average annual cases over 2016-2020.
- CI*Rank⋔ : 38 (24, 43)
- Percent of Cases with Late Stage : 62.5
Kansas6
- Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.4 to 10.8 and 186 average annual cases over 2016-2020.
- CI*Rank⋔ : 19 (5, 35)
- Percent of Cases with Late Stage : 65.9
Oklahoma6
- Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.6 to 9.7 and 228 average annual cases over 2016-2020.
- CI*Rank⋔ : 37 (21, 41)
- Percent of Cases with Late Stage : 61.9
Iowa3
- Rate : The incidence rate is 12.1 with a 95% confidence interval from 11.5 to 12.9 and 254 average annual cases over 2016-2020.
- CI*Rank⋔ : 1 (1, 6)
- Percent of Cases with Late Stage : 68.7
Alabama6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.3 to 8.1 and 257 average annual cases over 2016-2020.
- CI*Rank⋔ : 45 (41, 48)
- Percent of Cases with Late Stage : 62.4
Oregon6
- Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.8 to 9.9 and 259 average annual cases over 2016-2020.
- CI*Rank⋔ : 33 (17, 40)
- Percent of Cases with Late Stage : 62.7
Connecticut3
- Rate : The incidence rate is 10.7 with a 95% confidence interval from 10.1 to 11.3 and 268 average annual cases over 2016-2020.
- CI*Rank⋔ : 8 (2, 26)
- Percent of Cases with Late Stage : 61.5
South Carolina6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.4 to 8.2 and 276 average annual cases over 2016-2020.
- CI*Rank⋔ : 43 (40, 48)
- Percent of Cases with Late Stage : 62.5
Louisiana3
- Rate : The incidence rate is 10.0 with a 95% confidence interval from 9.5 to 10.6 and 296 average annual cases over 2016-2020.
- CI*Rank⋔ : 21 (7, 33)
- Percent of Cases with Late Stage : 64.9
Colorado6
- Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.7 to 9.7 and 304 average annual cases over 2016-2020.
- CI*Rank⋔ : 35 (21, 40)
- Percent of Cases with Late Stage : 68.6
Kentucky3
- Rate : The incidence rate is 11.3 with a 95% confidence interval from 10.7 to 11.9 and 337 average annual cases over 2016-2020.
- CI*Rank⋔ : 4 (1, 14)
- Percent of Cases with Late Stage : 68.9
Arizona6
- Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.8 to 7.5 and 343 average annual cases over 2016-2020.
- CI*Rank⋔ : 48 (44, 49)
- Percent of Cases with Late Stage : 61.2
Minnesota6
- Rate : The incidence rate is 10.7 with a 95% confidence interval from 10.2 to 11.2 and 386 average annual cases over 2016-2020.
- CI*Rank⋔ : 7 (3, 22)
- Percent of Cases with Late Stage : 61.4
Tennessee6
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.2 to 9.0 and 386 average annual cases over 2016-2020.
- CI*Rank⋔ : 40 (33, 43)
- Percent of Cases with Late Stage : 60.9
Maryland6
- Rate : The incidence rate is 10.0 with a 95% confidence interval from 9.6 to 10.5 and 395 average annual cases over 2016-2020.
- CI*Rank⋔ : 22 (9, 34)
- Percent of Cases with Late Stage : 68.5
Missouri6
- Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.8 to 10.7 and 426 average annual cases over 2016-2020.
- CI*Rank⋔ : 16 (6, 30)
- Percent of Cases with Late Stage : 67.1
Wisconsin6
- Rate : The incidence rate is 11.5 with a 95% confidence interval from 11.0 to 12.0 and 449 average annual cases over 2016-2020.
- CI*Rank⋔ : 2 (1, 9)
- Percent of Cases with Late Stage : 69.1
Washington5
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.4 to 10.2 and 455 average annual cases over 2016-2020.
- CI*Rank⋔ : 26 (13, 35)
- Percent of Cases with Late Stage : 62.4
Virginia6
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.3 to 9.0 and 466 average annual cases over 2016-2020.
- CI*Rank⋔ : 39 (33, 43)
- Percent of Cases with Late Stage : 62.6
Massachusetts3
- Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.6 to 10.5 and 471 average annual cases over 2016-2020.
- CI*Rank⋔ : 20 (9, 32)
- Percent of Cases with Late Stage : 65.1
Georgia3
- Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.8 to 9.5 and 569 average annual cases over 2016-2020.
- CI*Rank⋔ : 36 (26, 40)
- Percent of Cases with Late Stage : 64.2
New Jersey3
- Rate : The incidence rate is 10.4 with a 95% confidence interval from 10.0 to 10.8 and 625 average annual cases over 2016-2020.
- CI*Rank⋔ : 13 (5, 26)
- Percent of Cases with Late Stage : 59.2
North Carolina6
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.5 to 10.2 and 673 average annual cases over 2016-2020.
- CI*Rank⋔ : 24 (14, 33)
- Percent of Cases with Late Stage : 68.0
Michigan6
- Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.8 to 10.6 and 688 average annual cases over 2016-2020.
- CI*Rank⋔ : 17 (8, 28)
- Percent of Cases with Late Stage : 65.7
Ohio6
- Rate : The incidence rate is 10.6 with a 95% confidence interval from 10.3 to 10.9 and 843 average annual cases over 2016-2020.
- CI*Rank⋔ : 10 (5, 20)
- Percent of Cases with Late Stage : 68.3
Illinois3
- Rate : The incidence rate is 10.3 with a 95% confidence interval from 10.0 to 10.6 and 846 average annual cases over 2016-2020.
- CI*Rank⋔ : 14 (7, 25)
- Percent of Cases with Late Stage : 65.3
Pennsylvania6
- Rate : The incidence rate is 11.1 with a 95% confidence interval from 10.8 to 11.4 and 1,020 average annual cases over 2016-2020.
- CI*Rank⋔ : 6 (2, 11)
- Percent of Cases with Late Stage : 66.6
Texas3
- Rate : The incidence rate is 8.3 with a 95% confidence interval from 8.1 to 8.5 and 1,277 average annual cases over 2016-2020.
- CI*Rank⋔ : 41 (38, 44)
- Percent of Cases with Late Stage : 58.3
New York3
- Rate : The incidence rate is 10.6 with a 95% confidence interval from 10.4 to 10.9 and 1,390 average annual cases over 2016-2020.
- CI*Rank⋔ : 9 (5, 19)
- Percent of Cases with Late Stage : 59.8
Florida6
- Rate : The incidence rate is 9.4 with a 95% confidence interval from 9.2 to 9.7 and 1,494 average annual cases over 2016-2020.
- CI*Rank⋔ : 30 (23, 36)
- Percent of Cases with Late Stage : 51.8
California3
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.4 to 9.8 and 2,250 average annual cases over 2016-2020.
- CI*Rank⋔ : 29 (21, 34)
- Percent of Cases with Late Stage : 65.3
- Rate : Data not available for this combination of data selections.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : data not available
- Rate : Data not available for this combination of data selections.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 07/04/2024 10:04 pm.
State Cancer Registries may provide more current or more local data.
Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.